SpaceX initiated, Humana upgraded: Wall Street's top analyst calls
Baird upgraded Humana (HUM) to Outperform with a $596 price target, citing 2028 EPS confidence. Oppenheimer upgraded Fastly (FSLY) to Outperform with a $35 target, noting AI traffic growth. Monness Crespi upgraded Elastic (ESTC) to Buy with a $120 target, praising execution. Morgan Stanley double-upgraded Cboe (CBOE) to Overweight with a $358 target, citing S&P contract renewal. Barclays initiated SpaceX (SPCX) with Overweight and $254 target, calling it an industrial revolution play.
How this was made
The 30-second read
Why it matters
Collective upgrades suggest a modest bullish bias, while downgrades temper optimism for industrials.
Market read
Analyst rating changes can move individual stocks and influence sector sentiment.
What to watch
Potential earnings pressure or macro headwinds not addressed in the upgrades.
Background
The article aggregates recent analyst rating changes and initiations across multiple US-listed companies.
Ticker impact
Baird upgraded Humana to Outperform with a $596 price target, indicating higher earnings confidence.
likely upward pressure from upgraded rating and higher target.
Upgrade and target increase suggest improved earnings outlook.
Oppenheimer upgraded Fastly to Outperform with a $35 target, citing AI traffic growth.
upward pressure as investors price in AI growth.
Upgrade reflects stronger growth expectations.
Monness Crespi upgraded Elastic to Buy with a $120 target after salesforce segmentation improvement.
upward pressure from upgraded stance.
Improved segmentation and buy rating signal better performance.
Morgan Stanley double upgraded Cboe Global Markets to Overweight with a $358 target after S&P contract renewal.
likely upward as contract removes overhang.
Contract renewal removes a key risk.
JPMorgan upgraded VF Corp. to Neutral from Underweight with unchanged $18 target.
limited impact, modest upside potential.
Upgrade is modest with no target change.
JPMorgan downgraded DuPont to Neutral from Overweight with a $145 target, citing demand slowdown.
downward pressure from lower rating.
Demand concerns drive downgrade.
JPMorgan downgraded Illinois Tool Works to Neutral from Overweight with a $270 target.
downward pressure as rating falls.
Rating cut reflects weaker outlook.
Keefe Bruyette downgraded Voya Financial to Market Perform with a $108 target, trimming EPS estimates.
downward pressure from lower target and EPS cuts.
Reduced estimates signal weaker performance.
Market effects
Broad analyst upgrades may lift tech and industrial sectors.
US equity markets may see modest gains in covered sectors.
Limited to US-listed equities; no global macro effect.
Counterpoint
Some upgrades may be premature given broader market volatility.
Key entities
- Research FirmBaird
Provided upgrade to Humana.
- Research FirmOppenheimer
Upgraded Fastly.
- Research FirmMorgan Stanley
Upgraded CBOE, downgraded DuPont and ITW.
